It was found that the proportion of CD4+ T cells in mouse tumor tissues increased from 42.1% to 55.5% after NP4 treatment, while the proportion of CD8+ T cells increased from 19.0% to 28.9% (Fig. 8d, e). Here, CD8A is linked to neoplasm.